Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997 Jun;41(6):1399-402.
doi: 10.1128/AAC.41.6.1399.

Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers

Affiliations
Clinical Trial

Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers

K A Rodvold et al. Antimicrob Agents Chemother. 1997 Jun.

Abstract

The steady-state concentrations of clarithromycin and azithromycin in plasma were compared with concomitant concentrations in epithelial lining fluid (ELF) and alveolar macrophages (AM) obtained in intrapulmonary samples during bronchoscopy and bronchoalveolar lavage from 40 healthy, nonsmoking adult volunteers. Mean plasma clarithromycin, 14-(R)-hydroxyclarithromycin, and azithromycin concentrations were similar to those previously reported. Clarithromycin was extensively concentrated in ELF (range of mean +/- standard deviation concentrations, 34.4 +/- 29.3 microg/ml at 4 h to 4.6 +/- 3.7 microg/ml at 24 h) and AM (480 +/- 533 microg/ml at 4 h to 99 +/- 50 microg/ml at 24 h). The concentrations of azithromycin in ELF were 1.01 +/- 0.45 microg/ml at 4 h to 1.22 +/- 0.59 microg/ml at 24 h, and those in AM were 42.7 +/- 28.7 microg/ml at 4 h to 41.7 +/- 12.1 microg/ml at 24 h. The concentrations of 14-(R)-hydroxyclarithromycin in the AM ranged from 89.3 +/- 52.8 microg/ml at 4 h to 31.3 +/- 17.7 microg/ml at 24 h. During the period of 24 h after drug administration, azithromycin and clarithromycin achieved mean concentrations in ELF and AM higher than the concomitant concentrations in plasma.

PubMed Disclaimer

References

    1. J Chromatogr. 1991 Apr 19;565(1-2):321-37 - PubMed
    1. J Antimicrob Chemother. 1991 Feb;27 Suppl A:61-5 - PubMed
    1. Eur J Clin Microbiol Infect Dis. 1991 Oct;10(10):859-61 - PubMed
    1. Clin Pharm. 1992 Feb;11(2):137-52 - PubMed
    1. J Chromatogr. 1991 Nov 15;571(1-2):199-208 - PubMed

Publication types

MeSH terms